Skip to main content

ResearchHubLoading navigation…

Loading ResearchHub…

International Journal of Antimicrobial Agents - ResearchHub

Explore the network

Research, people, journals and institutions — all in one place.

Explore

01Research 02Smart search 03Researchers 04Journals 05Institutions 06RHR Rankings 07ResearchHub platform 08Events

Work together

Turn ideas into projects, questions and reusable datasets.

Connect

01Projects 02Questions 03Datasets

Stay informed

Follow trends, opportunities and your research library.

Insights

01Research trends 02Opportunities 03Library 04Research services 05ResearchHub Pro 06Pricing

ResearchHub

Explore ResearchHub.

Personal

01Recommended research 02Research intelligence

Home Search Network Library Log in

ResearchHub

Research, connected

Explore the graph

ResearchGate

Download ResearchHub

GET IT ONGoogle PlayComing soonDownload on theApp StoreComing soonEXPLORE IT ONAppGalleryComing soon

Research

Research Researchers Journals Institutions RHR Rankings

Contribute

Projects Questions Datasets Opportunities

Platform

ResearchHub platform About Blog Community Help API Licensing

Shopping

Contact and support

Need help, have a question, or want to contact the ResearchHub team?

Contact and support support@aresearch.uk

© 2026 ResearchHub. Built for responsible scholarly connection.

Help Article feed Privacy Terms Cookies This work is licensed under Creative Commons Attribution 4.0 InternationalCC BY 4.0

Privacy-aware community infrastructure

Journal

International Journal of Antimicrobial Agents

0924-8579 · Elsevier BV

14 verified public works

Browse all journals →

Antibacterial dose optimization in patients with febrile neutropenia: Are we targeting the right patients and the right endpoints?

2026 · 0 citations

In reply to the Letter to the Editor regarding ‘Stepwise within-host evolution of a blaCTX-M-27-positive Klebsiella pneumoniae clone under changing antimicrobial pressures leading to enhancement of β-lactam resistance’

2026 · 0 citations

Vancomycin treatment outcomes and machine learning-based identification of heterogeneous vancomycin-intermediate Staphylococcus aureus infections

2026 · 0 citations

Disk diffusion and ETEST (gradient diffusion) may produce false susceptible results for Pseudomonas aeruginosa from cystic fibrosis patients due to inducible colistin tolerance

2026 · 0 citations

Ceftazidime-avibactam for the treatment of infections caused by carbapenem-resistant Gram-negative pathogens in Chinese patients: A phase IV, multi-center, open‑label study

2026 · 0 citations

Biomedical Applications of Antimicrobial Peptides: Multifunctional Mechanisms, Engineering Strategies, and Therapeutic Development

2026 · 0 citations

OmpK36 Alterations Are Associated with Reduced Imipenem/Relebactam Susceptibility in KPC-2–Producing Klebsiella pneumoniae, with Dose-Dependent Restoration at Higher Relebactam Concentrations

2026 · 0 citations

Convergence of carbapenem resistance and hypervirulence in Klebsiella pneumoniae in Europe: a systematic review

2026 · 0 citations

Efficacy and Safety of P-CABs-Based Bismuth Quadruple Therapy for First-line Helicobacter pylori Eradication: A Real-World Evidence Study

2026 · 0 citations

Virologic Outcomes of Bictegravir/Emtricitabine/Tenofovir Alafenamide in Advanced HIV-1 Disease: A Propensity-Weighted Multicenter Cohort Study

2026 · 0 citations

Response to the Comment on “Burden and global distribution of antimicrobial resistance in non-bloodstream infections among adults with cirrhosis: a systematic review and proportional meta-analysis”

2026 · 0 citations

The Pitfalls of HIV-1 DNA Resistance Genotyping: What it can and cannot tell us

2026 · 0 citations

Combined antibacterial activity of imipenem-funobactam with different antibiotics against carbapenem-resistant gram-negative bacteria in China

2026 · 0 citations

Association between Beta-Lactam concentration and Liver Injury in Critically Ill Patients

2026 · 0 citations

Page 1 of 1